The purpose of this study is to determine if an increased protein intake can attenuate the suppression of metabolic and anabolic hormones during caloric restriction
1. Preliminary testing Prior to the study start, participants will be weighed and body composition will be determined using calipermetry (7 sites) and bioelectrical impedance. Peak oxygen uptake (VO2peak) will be assessed using an incremental exercise test on a bicycle ergometer. 2. Randomization Participants will proceed through each of the following conditions lasting 5 days: CR-LP: Participants will be restricted to 30 kcal/kg FFM/day and protein intake will be low (0.8 g/kg BW/day). CR-HP: Participants will be restricted to 30 kcal/kg FFM/day and protein intake will be high (1.7 g/kg BW/day). CON: Participants will be in energy balance and consume 1.7 g protein/kg BW/day. 3. Diet Prescription Dietary energy intake will be controlled using clinical products and maltodextrin to meet target energy intakes. Participants will received calcium and Vitamin D supplementation throughout the study. 4. Exercise Prescription During all conditions, participants will conduct daily supervised exercise on a bicycle ergometer at an exercise intensity of 60% VO2peak. Exercise duration will be adjusted individually such that exercise energy expenditure will amount to 15 kcal/kg FFM/day. Additional exercise and intense physical activity will be prohibited. 5. Assessments The following assessments will be conducted prior to the start of each condition as well as upon completion of each condition: body weight and composition (impedance), fasting blood draw for assessment of metabolic and anabolic hormones, resting metabolic rate, aerobic fitness (VO2peak), and questionnaires. 6. Washout Once a participant has completed a study condition, participant will be allowed a washout of at least 14 days to allow protein balance to return to baseline (Hoffer \& Forse, 1990). During this time, participants will resume their regular diet and physical activity.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
20
Participants will consume 30 kcal/kg FFM/day.
Participants will consume 1.7 g protein/kg BW/day.
Participants will conduct aerobic exercise designed to expend 15 kcal/kg FFM/day
Sports and Exercise Nutrition Laboratory, Department of Nutrition and Health Sciences, Ruth Leverton Hall
Lincoln, Nebraska, United States
Change in Resting Metabolic Rate
Time frame: Baseline and day 6
Change in Circulating IGF-1
Time frame: Baseline and day 6
Change in Marker of Bone Formation (P1NP)
Time frame: Baseline and day 6
Change in Marker of Bone Resorption (CTx)
Time frame: Baseline and day 6
Change in Body Weight
Time frame: Baseline and day 6
Change in Body Fat Percentage
Time frame: Baseline and day 6
Change in Aerobic Fitness (VO2peak)
Analyzed in L/min rather than mL/kg/min to remove influence of weight loss.
Time frame: Baseline and day 6
Change in Perceived Hunger
Perceived hunger will be assessed using 0-100 visual analog scales. In this case, 100 means maximum hunger while 0 means minimal hunger.
Time frame: Baseline and day 6
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Participants will be provided calcium and vitamin D supplement in order to maintain calcium and Vitamin D intake constant across all study arms
Participants will be provided with maltodextrin to supplement the liquid diet in order to meet caloric needs within each study arm